Achilles Therapeutics Plc (ACHL) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Achilles Therapeutics Plc, a biopharmaceutical company, has received a notice from Nasdaq for not meeting the minimum bid price requirement but remains listed on the Nasdaq Global Select Market. The company has 180 days to comply with the $1.00 minimum bid price rule by maintaining its share price above that threshold for at least ten consecutive business days. Despite the notice, Achilles Therapeutics’ operations remain unaffected, and it is exploring options to regain compliance.
For further insights into ACHL stock, check out TipRanks’ Stock Analysis page.
